Antibody cocktail means happy days for treating mild Covid

AstraZeneca drug halves the risk of developing severe illness or death, tests reveal

11 October 2021 - 19:33 By Suzi Ring

AstraZeneca’s antibody cocktail was effective at preventing people with mild or moderate Covid-19 infection from worsening in a study that bolsters the drugmaker’s ambitions for the product.

The cocktail halved the risk of developing severe illness or death compared with a placebo in 822 participants who had been symptomatic for a week or less and weren’t hospitalised, Astra said in a statement on Monday. ..

This article is free to read if you register or sign in.

If you have already registered or subscribed, please sign in to continue.

Questions or problems? Email or call 0860 52 52 00.